Skip to main content

Table 1 Prior NICU studies examining C. difficile prevalence

From: Clostridium difficile stool shedding in infants hospitalized in two neonatal intensive care units is lower than previous point prevalence estimates using molecular diagnostic methods

Author, Year of Study

Location

Test Methods

Prevalence of C. difficile

Kim, 1981 [37]

U.S.

Culture + cytotoxicity assay

21% culture +, 14% toxin +

Blakey, 1982 [31]

Australia

Culture

0–35% culture +a

Donta, 1982 [18]

U.S.

Cytotoxicity assay

54.9% toxin +

Sherertz, 1982 [25]

U.S.

Culture

59% culture +

Malamou-Ladas, 1983 [39]

England

Culture

54% culture +

Al-Jumaili, 1984 [13]

England

Culture + cytotoxicity assay

71% culture +, 45% toxin +

Lishman, 1984 [38]

England

Culture + cytotoxicity assay

78% culture +, 67% toxin +

Phua, 1984 [40]

England

Culture + cytotoxicity assay

21% culture +, 0% toxin +

Zedd, 1984 [42]

U.S.

Culture

41% culture +

Cardines, 1988 [32]

Italy

Culture + cytotoxicity assay + PAGEb

63% culture +, 0% toxin + (per cytotoxicity assay), 16% toxigenic strain + (per PAGE)

el-Mohandes, 1993 [34]

U.S.

Culture + cytotoxicity assay

15–33% culture +, 71–100% toxin +c

Kato, 1994 [36]

Japan

Culture + PCR for toxins A and B

61% culture +, 6% toxin +d

Tina, 1994 [41]

Italy

Culture + EIA for toxins A and B

43.6% culture +, 31.2% toxin +

Enad, 1997 [19]

U.S.

EIA for toxin A

52% EIA +

Alfa, 2002 [30]

Canada

PCR for C. difficile 16S gene

21% C. difficile 16S gene +

Chang, 2012 [33]

Korea

PCR for C. difficile 16S gene

+ PCR for toxins A and B

34.7–53.1% C. difficile 16S gene+e

23.5–30.8% toxin +

Ferraris, 2012 [35]

France

PCR for C. difficile 16S gene

42.1% C. difficile 16S gene+

Faden, 2015 [20]

U.S.

EIA GDH Ag/toxins A/B

C. difficile culture

25.7% +f

  1. aStudy measured prevalence at days 0–4, 5–8, 9–12, 13–16, 17–20 and > 20 days, thus providing a prevalence range
  2. bSDS-polyacrylamide gel electrophoresis (PAGE) of EDTA-extracted proteins used to identify toxigenic strains
  3. cStudy measured prevalence after 1 week of enteral feeding, at 15 +/− 1 days of life; 2 more specimens were collected at 2 week intervals, 24 +/− 1 and 32 +/− 2 days of life, thus providing a prevalence range
  4. dPCR for toxins A and B were performed on only 32 of 41 C. difficile culture+ infants
  5. eStudy measured prevalence within 72 h of birth, 1, 2, and 4–6 weeks of age thus providing a prevalence range
  6. fTest modality of positivity unspecified